Additionally, Batista et al. identified multiple insulin signaling defects in myocytes from T2D iPSCs, including issues with Rho-GTPase regulation, vesicular trafficking, and nuclear processes [107]. The gene discussed is INS; the disease is type 2 diabetes mellitus.